From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.
Partner News | Published: Friday, February 26, 2021
ScImage, Inc., a leading provider of Enterprise Imaging solutions, announces it has received Frost & Sullivan’s 2020 North America Enabling Technology Leadership Award for its Cloud-based Enterprise Imaging Solutions.
Genetesis Applauds CMS’s MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices
Partner News | Published: Wednesday, January 13, 2021The Centers for Medicare & Medicaid Services (CMS) announced the establishment of the Medicare Coverage of Innovative Technology (MCIT) pathway, to bring new and innovative technologies to beneficiaries
Partner News | Published: Tuesday, January 12, 2021ScImage, Inc., a leading provider of Enterprise Imaging solutions, announces significant expansion of deploying end-to-end diagnostic imaging workflows entirely in the Cloud for Cardiology, Vascular,
Partner News | Published: Wednesday, January 6, 2021
Magnetocardiography (MCG) has been assessed over the last 30 years as a rapid diagnostic tool for various forms of cardiac pathophysiology. MCG is able to detect and discern miniscule differences in the magnetic fields generated by the heart’s natural pacemaker activity. These fields have previously been shown to change with cardiac ischemia due to dysfunction of the ion channels responsible for repolarization and depolarization of the myocardium.
Partner News | Published: Wednesday, December 16, 2020By Marc Toth, Vice President of Cardiovascular Services, Atlas Healthcare Partners and Meredith Banasiak, EDAC, Director of Research, Boulder Associates, Inc. It is anticipated that by 2030, 82% of all
Partner News | Published: Tuesday, December 15, 2020Genetesis, Inc., a MedAxiom partner, announced today that its flagship product, CardioFlux®, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for the
Partner News | Published: Tuesday, December 8, 2020Biome Analytics, the leading cardiovascular performance company announced that they have expanded the Board of Directors with the appointment of Jim Andrews. Andrews is currently senior vice president,
Partner News | Published: Monday, December 7, 2020
The link between moderate-to-severe sleep apnea (SA) and serious cardiovascular disease (CVD) has been broadly accepted. Undiagnosed sleep apnea is a major comorbidity of CVD and a significant risk factor for atrial fibrillation, stroke, congestive heart failure, and hypertension.
Partner News | Published: Monday, November 30, 2020
Varsity Healthcare Partners (“VHP”), a leading healthcare services private equity investment firm, announced a growth equity investment with Partners First Cardiology (“Partners First”, “PFC”, or “the Company”).
Partner News | Published: Thursday, November 19, 2020
Partners First Cardiology, a physician practice Management Services Organization (MSO) that has a practice management solution designed exclusively for cardiologists.